This role ensures safe, evidence-based withdrawal management; supervises medical and nursing personnel; directs integrated care planning; and supports the organization’s technology-enhanced treatment model, including comprehensive EEG assessments, neuromodulation, hydrogen therapy, red-light therapy, NSS-2 Bridge, the proprietary BioMatrix Index™, exclusive contract with FDA-approved dinucleotide to minimize withdrawal symptoms, and acupuncture as clinically appropriate. The Medical Director (MD/DO) provides medical leadership, governance, and direct clinical oversight for NOVA ViA DX LLC’s 36-bed acute medical detox.